Ahmed Raslan, MD
Neurological Surgery · Portland, ORNPI 1356550206
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Abbott at 52.3% of the total. Reporting peaked in 2021 at $16,451 and has fallen 84.4% since, to $2,573 in 2025.
Across 148 payments — averaging $220.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$17K
- Biotronik Inc.$7K
- Insightec,inc$3K
- Medtronic$1K
- GE HealthCare$1K
- Boston Scientific$1K
- plus $1K from 8 others
Across 141 payments — averaging $7454.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Servier Bioinnovation$912K
- Springworks Therapeutics, Inc.$103K
- Medtronic$31K
- Abbott$3K
- Insightec,ltd$3K
What the payments were for
- Consulting fees$8,22025%
- Speaking & faculty fees$13,55041%
- Grants$1330%
- Travel & lodging$4,80915%
- Food & beverage$5,97618%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 50 | $17,080 |
| Biotronik Inc. | 4 | $7,087 |
| Insightec,inc | 39 | $3,298 |
| Medtronic(2 entities) | 16 | $1,293 |
| GE HealthCare | 2 | $1,250 |
| Boston Scientific | 23 | $1,192 |
| Biogen | 1 | $565 |
| Saluda Medical Americas, Inc. | 5 | $287 |
| Biotronik NRO, Inc. | 2 | $146 |
| PTC Therapeutics, Inc. | 1 | $128 |
| SPR Therapeutics, Inc | 1 | $116 |
| Neuropace, Inc. | 1 | $111 |
| Carlsmed, Inc. | 1 | $82 |
| Zimmer Biomet | 2 | $53 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$6,780
- IonicRF Generator$5,400
- Proclaim DRG IPG$2,705
- Exablate$2,214
- Proclaim IPG$912
- ACTIVA$580
- GENERAL DBS$448
- Proclaim Family of SCS IPGs$308
- Axium$292
- VISUALASE$270
- S-Series SCS Leads$140
- Neuromodulation Dspsbls and Accs$126
- Prospera$123
- SPRINT PNS System$116
- RNS System$111
- SPECTRA WAVEWRITER$105
- Evoke SCS$104
How this compares
$32,688 in reported general payments places this provider in the 85th percentile of 95 neurological surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 15 | $160 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Portland
- Josha WoodwardPortland$145K
- Seth OliveriaPortland$97K
- Daniel ClearyPortland$63K
- Helen ShiPortland$61K
- Adam LipsonPortland$59K
- David AntezanaPortland$50K
- Christina WrightPortland$47K
- Kim BurchielPortland$28K
- Martin BaggenstosPortland$22K
- Aqib ZehriPortland$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.